E-Newsletter: July 24, 2019

Hello,

Can you believe we’re almost half way through summer?  Time sure does fly.  Speaking of flying, today we proudly honor the famous aviation pioneer and author, Amelia Earhart. Earhart was the first female aviator to fly solo across the Atlantic Ocean, and was instrumental in the formation of The Ninety-Nines, an organization for female pilots. Happy Amelia Earhart Day!

In this week’s edition of Alzheimer’s Research News You Can Use, our first article covers how researchers discovered that specialized brain scans can have a big impact on the way doctors manage the care of patients’ with Alzheimer’s disease.  Our second article shares the difficult but necessary decision drug companies, Biogen and Eisai made in terminating late stage testing of what looked to be a promising new drug for Alzheimer’s.  While this announcement is deeply disappointing, it emphasizes the difficulty of developing new treatments for this devastating disease that affects millions of people around the world.

To learn more about the aforementioned research, please read the expert-reviewed articles below.  For more information about Alzheimer’s in general, please visit our website at www.alzinfo.org.

Thank you for your interest in learning more about the research progress being made at the Fisher Center.

Together we can end Alzheimer’s.

Sincerely,

Lucretia Holden
Senior Vice President

Research Articles

Doctor showing Alzheimer's Brain Scans

Brain Scans Aid in Management of Alzheimer’s Disease

May 17, 2019

Specialized brain scans can have a big impact on the Read More

Drug Companies Halt Trials of Aducanumab for Alzheimer’s Disease

July 2, 2019

The drug makers Biogen and Eisai have decided to abandon Read More

We consistently receive top awards and ratings for our accountability: